Recent research has shown that a small percentage of cells in bacterial cultures are non-growing persister cells. Although the mechanism of persister formation remains elusive, it is well accepted that the persister cells are not mutants with growth defects, but rather phenotypic variants of the wild-type strain. The dormant nature of persister cells allows them to escape the killing by antibiotics, presenting a great challenge to curing chronic infections. In this presentation, we report for the first time that the persister cells can be effectively inactivated by low-level direct currents (DCs). After treatment with 75 µA/cm2 DC using graphite electrodes for 60 minutes, the viable persister cells of Escherichia coli HM22 in 0.85% NaCl buffer decreased from 5.7×105 to 9.4×102 CFU/mL. In contrast, incubation for 60 minutes in 0.85% NaCl pretreated with the same level and duration of DC only reduced the viable cells from 1.2×106 to 1.2×105 CFU/mL. In addition to inactivation by applying DC alone, synergistic effects were observed when treating persister cells with DC and antibiotic together. As expected, treatment with 100 µg/mL ampicillin (Amp), 20 µg/mL cinoxacin (Cn) or 20 µg/mL tobramycin (Tb) alone only caused slight reduction in the number of viable persister cells. In the presence of 75 µA/cm2 DC, however, the viable persister cells were reduced from 5.2×105 to 1.7×104 CFU/mL by 100 µg/mL Amp, from 1.1×106 to 2.3 CFU/mL by 20 µg/mL Cn, and from 1.0×106 to 23 CFU/mL by 20 µg/mL Tb. These data indicate that the efficacy of Amp, Cn and Tb increased approximately by 30, 70000 and 12000 times respectively by 75 µA/cm2 DC, compared to the treatments without DC. The possible mechanism of these effects will be discussed. These results are helpful for understanding the mechanism of persister formation and for developing novel control methods.
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division